Best of August 2025: Top 5 Insights In Drug Formulation & Delivery

#1 - Understanding Annex 1 For Sterile Medicinal Products

In this article, Fran DeGrazio highlights key considerations for the manufacturing of sterile products and offers recommendations for contamination control, facilities upgrades, quality risk management, testing, inspections, and personnel training.

#2 - Charting The Waters Of Drug Delivery Innovation With Suttons Creek

In this episode ofIn Combination, the technical leadership team from device consultancy Suttons Creek joins host Tom von Gunden to discuss trends in the patient landscape driving innovation in drug delivery, including combination products and therapies. 

#3 - Delivering Therapies To The Olfactory Region

Olfactory loss presents a unique set of challenges. Discover how Cyrano is developing a spray technology with a soft mist, specific droplet size, and low velocity to reach the upper nasal cavity.

#4 - De-Risking The Transition From Vial To Drug-Device Combination Product

When transitioning from a vial to a combination product system, the best approach is to have a holistic de-risk strategy with an intentional focus on the patient, the plan, and the product.

#5 - All Of Us Need To Be Rooting For The FDA

Halo Biosciences is building a pipeline based on novel insights into how extracellular matrix dysregulation drives disease. We caught up with its leaders to discuss their approach to drug targeting and early development.